• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺式-2,4-亚甲基谷氨酸是一种强效且具有选择性的N-甲基-D-天冬氨酸受体激动剂。

Cis-2,4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist.

作者信息

Lanthorn T H, Hood W F, Watson G B, Compton R P, Rader R K, Gaoni Y, Monahan J B

机构信息

CNS Diseases Research, G.D. Searle & Co., St. Louis, MO.

出版信息

Eur J Pharmacol. 1990 Jul 17;182(3):397-404. doi: 10.1016/0014-2999(90)90036-6.

DOI:10.1016/0014-2999(90)90036-6
PMID:2146136
Abstract

Cis- and trans-2,4-methanoglutamate were compared with L-glutamate as acidic amino acid ligands. Cis-2,4-methanoglutamate had a Ki of 0.052 microM against N-methyl-D-aspartate (NMDA)-specific L-[3H]glutamate binding compared with 0.050 microM for L-glutamate. Cis-2,4-methanoglutamate exhibited no significant affinity against [3H]kainate or [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate ([3H]AMPA) binding. Trans-2,4-methanoglutamate had no significant affinity for any of these sites. Cis-2,4-methanoglutamate increased [3H]N-1[2-thienyl]cyclohexyl-3,4-piperidine [( 3H]TCP) binding with EC50 of 0.35 +/- 0.14 microM. It produced an inward current in rat brain mRNA-injected Xenopus oocytes which was blocked by the NMDA antagonist, D-2-amino-7-phosphonoheptanoate (D-AP7). Cis-2,4-methanoglutamate (EC50 = 15.9 microM) was 100-fold more potent than L-glutamate (EC50 = 1,584 microM) in reducing the excitatory postsynaptic potential in CA1 of hippocampal slices. Cis-2,4-methanoglutamate is the most potent, selective NMDA agonist known.

摘要

将顺式和反式-2,4-亚甲基谷氨酸作为酸性氨基酸配体与L-谷氨酸进行了比较。顺式-2,4-亚甲基谷氨酸对N-甲基-D-天冬氨酸(NMDA)特异性L-[3H]谷氨酸结合的Ki为0.052微摩尔,而L-谷氨酸为0.050微摩尔。顺式-2,4-亚甲基谷氨酸对[3H]海人藻酸或[3H]α-氨基-3-羟基-5-甲基-4-异恶唑丙酸([3H]AMPA)结合无明显亲和力。反式-2,4-亚甲基谷氨酸对这些位点均无明显亲和力。顺式-2,4-亚甲基谷氨酸使[3H]N-1-[2-噻吩基]环己基-3,4-哌啶([3H]TCP)结合增加,EC50为0.35±0.14微摩尔。它在注射大鼠脑mRNA的非洲爪蟾卵母细胞中产生内向电流,该电流被NMDA拮抗剂D-2-氨基-7-膦酰庚酸(D-AP7)阻断。在降低海马切片CA1区兴奋性突触后电位方面,顺式-2,4-亚甲基谷氨酸(EC50 = 15.9微摩尔)的效力比L-谷氨酸(EC50 = 1584微摩尔)强100倍。顺式-2,4-亚甲基谷氨酸是已知最强效、最具选择性的NMDA激动剂。

相似文献

1
Cis-2,4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist.顺式-2,4-亚甲基谷氨酸是一种强效且具有选择性的N-甲基-D-天冬氨酸受体激动剂。
Eur J Pharmacol. 1990 Jul 17;182(3):397-404. doi: 10.1016/0014-2999(90)90036-6.
2
CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.CGP 37849和CGP 39551:新型强效竞争性N-甲基-D-天冬氨酸受体拮抗剂,具有口服活性。
Br J Pharmacol. 1990 Apr;99(4):791-7. doi: 10.1111/j.1476-5381.1990.tb13008.x.
3
Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.喹喔啉衍生物:抑制N-甲基-D-天冬氨酸和非N-甲基-D-天冬氨酸受体介导的电流及突触电位的构效关系和生理意义
Mol Pharmacol. 1992 Feb;41(2):337-45.
4
Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.NPC 17742 [2R,4R,5S-(2-氨基-4,5-(1,2-环己基)-7-膦酰基庚酸)]的药理学特性,一种强效、选择性和竞争性N-甲基-D-天冬氨酸受体拮抗剂。
J Pharmacol Exp Ther. 1993 Jan;264(1):256-64.
5
The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.新型抗惊厥药MK-801与大鼠脑中N-甲基-D-天冬氨酸受体的激活状态相结合。
Br J Pharmacol. 1987 Jun;91(2):403-9. doi: 10.1111/j.1476-5381.1987.tb10295.x.
6
Selectivity of amino acid transmitters acting at N-methyl-D-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors.作用于N-甲基-D-天冬氨酸和3-羟基-5-甲基-4-异恶唑丙酸受体的氨基酸递质的选择性
Mol Pharmacol. 1992 Mar;41(3):520-6.
7
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonist.
Eur J Pharmacol. 1991 Oct 15;203(2):237-43. doi: 10.1016/0014-2999(91)90719-7.
8
Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
J Pharmacol Exp Ther. 1989 Jul;250(1):100-9.
9
Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.NMDA受体竞争性拮抗剂结合动力学的构效关系分析:构象限制的影响
Br J Pharmacol. 1991 Sep;104(1):207-21. doi: 10.1111/j.1476-5381.1991.tb12409.x.
10
Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains.
Eur J Pharmacol. 1992 Mar 12;225(3):195-201. doi: 10.1016/0922-4106(92)90020-v.

引用本文的文献

1
The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries.20 世纪 80 年代:D-AP5、LTP 和十年的 NMDA 受体发现。
Neurochem Res. 2019 Mar;44(3):516-530. doi: 10.1007/s11064-018-2640-6. Epub 2018 Oct 4.
2
Phencyclidine treatment in mice: effects on phencyclidine binding sites and glutamate uptake in cerebral cortex preparations.小鼠中的苯环利定治疗:对大脑皮质制剂中苯环利定结合位点和谷氨酸摄取的影响。
J Neural Transm Gen Sect. 1993;93(1):47-59. doi: 10.1007/BF01244937.
3
NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid.
哺乳动物组织中的NMDA受体异质性:聚焦于两种激动剂,(2S,3R,4S)环丙基谷氨酸和4-羟基-(S)-哌啶酸硫酸酯。
Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):371-6. doi: 10.1007/BF00169077.